Theravance has appointed Jeff Jonker as senior VP, corporate and business development.
He joins the US-based biopharma from Satori where he served as chief business officer.
In his new role, he will report to Theravance CEO Rick Winningham and will hold responsibility for managing the company’s business and corporate development affairs.
Prior to joining Satori, Jonker held senior roles at Genentech and Gloucester Pharmaceuticals.
“Jeff brings a wealth of industry and deal experience to Theravance,” said Winningham.
The CEO also commented that Jonkers’ appointment will support the companys’ plans to split into two biotech groups as its deals with GlaxoSmithKline are advanced.
“As Theravance separates into two companies, Jeff’s track record of building successful companies and establishing strong collaborations will be important to our future growth,” said Winningham.